方法： 158例老年绝经期骨质疏松症患者随机分为对照组（79例）和观察组（79例）。
METHODS: 158 elderly menopausal patients with osteoporosis were randomly divided into control group (79 cases) and observation group(79 cases).
与三苯氧胺不同的是，芳香抑制剂不会引起绝经期症状，但可增加骨质疏松症危险。
Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.
研究结果表明这种每年一次的疗法能降低所有绝经期后患骨质疏松症各种类型骨折的风险。
Results of the study showed that treatment with zoledronic acid was very effective in reducing the incidence of all types of fractures in women with postmenopausal osteoporosis.
研究结果表明这种每年一次的疗法能降低所有绝经期后患骨质疏松症各种类型骨折的风险。
Results of the study showed that treatment with zoledronic acid was very effective in reducing the incidence of all types of fractures in women with postmenopausal osteoporosis.
应用推荐